SNCA and Parkinson disease: The results showed that treatment with CPC NPs combined with UTMD in MPTP-induced PD mice notably improved behavioral disturbance, dopamine depletion, and TH expression, as well as reduced α-synuclein (AS) expression, showing that the delivery of CUR with this treatment was efficient, as well as its therapeutic effects against PD.